Profil
Jacob Thordenberg is currently Director at Bico International AB and Cellink Bioprinting AB. Mr. Thordenberg is also set to be Chief Financial Officer at Dynavox Group AB starting in 2026.
Formerly, Mr. Thordenberg was Director-Mergers & Acquisition at Telia Co. AB and Chief Financial Officer at BICO Group AB from 2023 to 2026.
Mr. Thordenberg graduated from the University of Lund.
Postes actifs de Jacob Thordenberg
| Sociétés | Poste | Début |
|---|---|---|
| TOBII DYNAVOX AB | Directeur Financier/CFO | 14/09/2026 |
Bico International AB | Directeur/Membre du Conseil | - |
Cellink Bioprinting AB
Cellink Bioprinting AB BiotechnologyHealth Technology Operates as 3D bioprinting company that provides drug development services | Directeur/Membre du Conseil | - |
Anciens postes connus de Jacob Thordenberg
| Sociétés | Poste | Fin |
|---|---|---|
| BICO GROUP AB | Directeur Financier/CFO | 01/03/2026 |
| TELIA COMPANY AB | Corporate Officer/Principal | - |
Formation de Jacob Thordenberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Telia Co. AB
Telia Co. AB Specialty TelecommunicationsCommunications Provides mobile telecommunications and advertising services & sells mobile devices | Communications |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BICO Group AB
BICO Group AB BiotechnologyHealth Technology Develops tools for bioprinting technology | Health Technology |
Tobii Dynavox AB
Tobii Dynavox AB Packaged SoftwareTechnology Services Develops assistive technology for communication | Technology Services |
Bico International AB | |
Cellink Bioprinting AB
Cellink Bioprinting AB BiotechnologyHealth Technology Operates as 3D bioprinting company that provides drug development services | Health Technology |
















